Join the FGI™ Waitlist

ImpriMed plans to launch FGI^™ in 2027, a new service designed to help distinguish feline inflammatory bowel disease (IBD) from low-grade intestinal T-cell lymphoma using just 1-2 mL of blood.

FGI™ aims to address the need for a less invasive approach to a diagnostic challenge that often requires intestinal biopsies collected through endoscopy or surgery.